InMed Pharmaceuticals Inc. (TSX:IN) (OTC:IMLFF) (FRA:MWG2)
IN
IMLFF
MWG2

InMed Pharmaceuticals Inc. (TSX:IN) (OTC:IMLFF) (FRA:MWG2) is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary bioinformatics database drug/disease targeting tool, cannabinoid biosynthesis technology, and drug development pipeline are the fundamental drivers of shareholder value.

V6C 1S4
https://www.inmedpharma.com/
1-778-945-0960
Canada

Ratings

There are no reviews yet.

Post your review

Directions to listing

Send Message to listing owner

InMed Pharmaceuticals Inc.